Anderson M A, Gusella J F
In Vitro. 1984 Nov;20(11):856-8. doi: 10.1007/BF02619631.
We have investigated the potential for using cyclosporin A to increase the efficiency with which Epstein-Barr virus-transformed human lymphoblast lines can be prepared. Use of this immunosuppressive drug has permitted the development of a procedure with success rates exceeding 95% despite the processing of very large numbers of samples.
我们研究了使用环孢素A提高制备爱泼斯坦-巴尔病毒转化的人淋巴母细胞系效率的可能性。尽管处理了大量样本,但使用这种免疫抑制药物已使一种成功率超过95%的方法得以开发。